Teachers Advisors LLC boosted its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 13.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 137,761 shares of the medical instruments supplier’s stock after buying an additional 16,577 shares during the period. Teachers Advisors LLC owned 0.25% of Merit Medical Systems worth $8,465,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Piedmont Investment Advisors Inc. boosted its stake in Merit Medical Systems by 7.4% in the 3rd quarter. Piedmont Investment Advisors Inc. now owns 12,588 shares of the medical instruments supplier’s stock worth $774,000 after buying an additional 863 shares during the last quarter. United Services Automobile Association lifted its stake in shares of Merit Medical Systems by 11.1% in the 2nd quarter. United Services Automobile Association now owns 11,087 shares of the medical instruments supplier’s stock valued at $568,000 after purchasing an additional 1,108 shares in the last quarter. Congress Asset Management Co. MA lifted its stake in shares of Merit Medical Systems by 0.9% in the 3rd quarter. Congress Asset Management Co. MA now owns 123,936 shares of the medical instruments supplier’s stock valued at $7,616,000 after purchasing an additional 1,121 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Merit Medical Systems by 7.8% in the 3rd quarter. State of Alaska Department of Revenue now owns 17,777 shares of the medical instruments supplier’s stock valued at $1,092,000 after purchasing an additional 1,290 shares in the last quarter. Finally, Louisiana State Employees Retirement System lifted its stake in shares of Merit Medical Systems by 6.6% in the 3rd quarter. Louisiana State Employees Retirement System now owns 24,100 shares of the medical instruments supplier’s stock valued at $1,481,000 after purchasing an additional 1,500 shares in the last quarter. 98.53% of the stock is currently owned by hedge funds and other institutional investors.

Merit Medical Systems stock traded up $1.02 during midday trading on Monday, hitting $56.83. 21,032 shares of the company were exchanged, compared to its average volume of 261,386. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.47 and a current ratio of 2.77. Merit Medical Systems, Inc. has a fifty-two week low of $41.55 and a fifty-two week high of $66.34. The firm has a market capitalization of $3.12 billion, a PE ratio of 44.39, a price-to-earnings-growth ratio of 2.18 and a beta of 1.12.

In other news, EVP Justin J. Lampropoulos sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, November 16th. The shares were sold at an average price of $61.01, for a total transaction of $1,220,200.00. Following the completion of the sale, the executive vice president now owns 20,000 shares in the company, valued at approximately $1,220,200. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Nolan E. Karras sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 29th. The stock was sold at an average price of $61.28, for a total transaction of $122,560.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 26,743 shares of company stock valued at $1,633,506. 5.16% of the stock is currently owned by company insiders.

Several equities analysts have recently weighed in on MMSI shares. Canaccord Genuity lifted their price objective on Merit Medical Systems from $70.00 to $72.00 and gave the company a “buy” rating in a research note on Friday, October 26th. ValuEngine raised Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, October 24th. BidaskClub lowered Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 5th. Zacks Investment Research raised Merit Medical Systems from a “sell” rating to a “buy” rating and set a $65.00 price objective on the stock in a research note on Monday, October 29th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $73.00 price objective on shares of Merit Medical Systems in a research note on Monday, December 17th. One research analyst has rated the stock with a sell rating, ten have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $67.60.

COPYRIGHT VIOLATION NOTICE: This article was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.thecerbatgem.com/2019/02/11/merit-medical-systems-inc-mmsi-shares-bought-by-teachers-advisors-llc.html.

Merit Medical Systems Profile

Merit Medical Systems, Inc engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups.

Further Reading: Find a Trading Strategy That Works

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.